About

Hello!

I’m Elizabeth Goldberg PhD ARNP. I am a dedicated health care provider and scientist with a passion for helping people attain their best health and well-being.
 
After earning my PhD in Medicinal Chemistry from the University of Washington, I began my career in biotechnology, working on drug discovery. It was during this time that I realized the traditional pharmaceutical approach wasn’t always the key to helping patients reach their full wellness potential. Eager to make a more holistic impact as a healthcare provider, I pursued education at Seattle University becoming an Advanced Practice Nurse Practitioner. To further my understanding of integrative medicine and treating the root cause of illness, I became an IFM Certified Practitioner in Functional Medicine.
 
I am enthusiastic about helping individuals explore healthy aging and achieving optimal health. I utilize a Functional Medicine approach that evaluates an individual’s unique history and risk factors. Through my medical expertise, cutting-edge lab testing, and scientifically backed methods, I will create highly personalized treatment plans that address the root causes of health issues. A scientist at heart, I continue to broaden and deepen my understanding and practice in specialty areas.
 
• AANP-C American Academy of Nurse Practitioners
• IFMCP Institute of Functional Medicine
• The SIBO Doctor course certificate
• Jill Crista Mold Illness course certificate
• Younger You Intensive for Practitioners certificate
• Seattle University – MS Nursing Family Practice
• University of Washington – PhD Medicinal Chemistry
• University of Tokyo – Post-doctoral Fellowship
• University of Washington – BS Chemistry
• Goldberg, E.M.S. & Taylor, S.M. (2015) Master’s Degree Scholarly Project. Understanding Dietary Interventions to Reduce Sugar Consumption: A Resource for Nurse Practitioners Working with Populations Experiencing Poverty
• Storch, E.M. (1998) Doctoral Degree Thesis. Experimental and Computational Investigations of the Stability and Dynamics of Cytochrome b5.
• Hom, K., Ma, Q.F., Wolfe, G., Zhang, H., Storch, E.M., Daggett, V., Basus, V.J., & Waskell, L. (2000).  NMR studies of the association of cytochrome b5 with cytochrome c. Biochemistry, 39(46), 14025-14039.
• Storch, E.M., Grinstead, J.S., Campbell, A.P., Daggett, V., & Atkins, W.M. (1999).
• Engineering out motion: a surface disulfide bond alters the mobility of tryptophan 22 in cytochrome b5 as probed by time-resolved fluorescence and 1H NMR experiments. Biochemistry, 38(16), 5065-5075.
• Storch, E.M., Daggett, V., & Atkins, W.M. (1999). Engineering out motion: introduction of a de novo disulfide bond and a salt bridge designed to close a dynamic cleft on the surface of cytochrome b5. Biochemistry, 38(16), 5054-5064.
• Storch, E.M. & Daggett, V. (1995). Molecular dynamics simulation of cytochrome b5: implications for protein-protein recognition. Biochemistry, 34(30), 9682-9693.
• Storch, E.M. & Daggett, V. (1996). Structural consequences of heme removal: molecular dynamics simulations of rat and bovine apocytochrome b5. Biochemistry, 35(36), 11596-115604.
• Wienkers, L.C., Wurden, C.J., Storch, E., Kunze, K.L., Rettie, A.E., Trager, W.F. (1996). Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metab Dispos, 24(5), 610-614.
• AANP-C American Academy of Nurse Practitioners
• IFMCP Institute of Functional Medicine
• The SIBO Doctor course certificate
• Jill Crista Mold Illness course certificate
• Younger You Intensive for Practitioners certificate
• Metabolic Approach to Cancer Terrain Practitioner - in progress, completion 02/2026
 
• Seattle University – MS Nursing Family Practice
• University of Washington – PhD Medicinal Chemistry
• University of Tokyo – Post-doctoral Fellowship
• University of Washington – BS Chemistry
• Goldberg, E.M.S. & Taylor, S.M. (2015) Master’s Degree Scholarly Project. Understanding Dietary Interventions to Reduce Sugar Consumption: A Resource for Nurse Practitioners Working with Populations Experiencing Poverty
• Storch, E.M. (1998) Doctoral Degree Thesis. Experimental and Computational Investigations of the Stability and Dynamics of Cytochrome b5.
• Hom, K., Ma, Q.F., Wolfe, G., Zhang, H., Storch, E.M., Daggett, V., Basus, V.J., & Waskell, L. (2000).  NMR studies of the association of cytochrome b5 with cytochrome c. Biochemistry, 39(46), 14025-14039.
• Storch, E.M., Grinstead, J.S., Campbell, A.P., Daggett, V., & Atkins, W.M. (1999). Engineering out motion: a surface disulfide bond alters the mobility of tryptophan 22 in cytochrome b5 as probed by time-resolved fluorescence and 1H NMR experiments. Biochemistry, 38(16), 5065-5075.
• Storch, E.M., Daggett, V., & Atkins, W.M. (1999). Engineering out motion: introduction of a de novo disulfide bond and a salt bridge designed to close a dynamic cleft on the surface of cytochrome b5. Biochemistry, 38(16), 5054-5064.
• Storch, E.M. & Daggett, V. (1995). Molecular dynamics simulation of cytochrome b5: implications for protein-protein recognition. Biochemistry, 34(30), 9682-9693.
• Storch, E.M. & Daggett, V. (1996). Structural consequences of heme removal: molecular dynamics simulations of rat and bovine apocytochrome b5. Biochemistry, 35(36), 11596-115604.
• Wienkers, L.C., Wurden, C.J., Storch, E., Kunze, K.L., Rettie, A.E., Trager, W.F. (1996). Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metab Dispos, 24(5), 610-614.